| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
B Activation



From the Pathology and Physiology Research Branch,*
Health Effects Laboratory Division, National Institute for Occupational
Safety and Health, and the Department of Basic Pharmaceutical
Sciences,
West Virginia University,
Morgantown, West Virginia, the Department of Medical
Chemistry,
Kochi Medical School, Kochi,
Japan, and the Department of Pathology,§
The
Pennsylvania State University College of Medicine,
Hershey, Pennsylvania
To evaluate the roles of nitric oxide (NO) on human
immunodeficiency virus (HIV) Tat-induced transactivation of HIV long
terminal repeat (HIV-LTR), we examined the effect of NO in the
regulation of nuclear factor (NF)-
B, a key transcription
factor involved in HIV gene expression and viral replication. In the
present study, we demonstrate that HIV Tat activates NF-
B
and that this activation can be attenuated by endogenous or exogenous
NO. Inhibition of endogenous NO production with the NO synthase (NOS)
inhibitor L-NMMA causes a significant increase in
Tat-induced NF-
B activity. In addition, NO attenuates
signal-initiated degradation of I
B
, an intracellular
inhibitor of NF-
B, and blocks the DNA binding activity of
the NF-
B p50/p50 homodimer and p50/p65 heterodimer. To determine how
NO is induced by HIV Tat, reverse transcription polymerase
chain reaction was used to demonstrate the induction of NOS-2 and NOS-3
mRNA by Tat. Although a putative NF-
B binding site was identified in
the -74 GGAGAGCCCCC -64 region of the NOS-3 gene promoter,
gel mobility shift assays and site-directed mutation analyses suggest
that the putative NF-
B site is not of primary importance.
Rather, several Sp-1 sites adjoining the putative NF-
B
binding site in the promoter region of NOS-3 gene are required for the
induction of NOS-3 gene expression by Tat.
This article has been cited by other articles:
![]() |
G. M. Pieper, C. L. Olds, J. D. Bub, and P. F. Lindholm Transfection of human endothelial cells with HIV-1 tat gene activates NF-kappa B and enhances monocyte adhesion Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2315 - H2321. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Dickie, A. Roberts, and R. Lee A defect in HIV-1 transgenic murine macrophages results in deficient nitric oxide production J. Leukoc. Biol., October 1, 2001; 70(4): 592 - 600. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Jimenez, J. Gonzalez-Nicolas, S. Alvarez, M. Fresno, and M. A. Munoz-Fernandez Regulation of Human Immunodeficiency Virus Type 1 Replication in Human T Lymphocytes by Nitric Oxide J. Virol., May 15, 2001; 75(10): 4655 - 4663. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Ponnappan and L. S. F. Soderberg Inflammatory macrophage nuclear factor-{kappa}B and proteasome activity are inhibited following exposure to inhaled isobutyl nitrite J. Leukoc. Biol., April 1, 2001; 69(4): 639 - 644. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |